+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Liquid Embolics global market

Liquid Embolics global market

Global Liquid Embolics Market Research Report 2025

This report on the global liquid embolics market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging trends, regional perfo

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Chem Reports – Global Liquid Embolics Market Forecast (2025–2035)

Market Prediction
The Liquid Embolics market was valued at USD xxxx units in 2024 and is projected to reach USD xxxx units by 2035, growing at a CAGR of xx% globally.

Global Liquid Embolics Market Overview

The Global Liquid Embolics Market Report 2020 provides an extensive industry analysis of development components, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2025–2035.

This research study utilized both primary and secondary data sources, examining parameters such as:

  • Government policy and regulatory environment
  • Market dynamics and competitive landscape
  • Historical data and current market trends
  • Technological innovation and upcoming advancements
  • Progress in related industries

Impact of COVID-19 on Liquid Embolics Market

Since the outbreak of COVID-19 in December 2019, the pandemic disrupted global supply chains, reduced hospital procedure volumes, and delayed elective treatments. The Liquid Embolics market was significantly affected in 2020, particularly in neurosurgical and oncology applications. Recovery has been underway with renewed demand for minimally invasive procedures, advanced embolization therapies, and improved patient outcomes.

Global Liquid Embolics Market Segmentation

By Type

  • Isobutyl-2-Cyanoacrylate (IBCA)
  • Ethanol
  • Sodium Morrhuate
  • Bletilla Striata
  • Others

By Application

  • Tumor and Brain Cancer
  • Brain Arteriovenous Malformations (AVMs)
  • Ischemic Stroke
  • Brain Aneurysm
  • Others

Regional Analysis

  • North America (U.S., Canada, Mexico): Strong demand for advanced embolization therapies; emphasis on FDA-approved products and high healthcare expenditure.
  • Europe (Germany, U.K., France, Italy, Russia, Spain, etc.): Mature market with strict EU medical device regulations; high adoption in neurosurgery and oncology.
  • Asia-Pacific (China, India, Japan, Southeast Asia, etc.): Fastest-growing region, driven by rising healthcare infrastructure, increasing incidence of neurological disorders, and adoption of minimally invasive procedures.
  • South America (Brazil, Argentina, etc.): Moderate growth supported by expanding healthcare systems; reliance on imports for premium embolic agents.
  • Middle East & Africa (Saudi Arabia, South Africa, etc.): Emerging demand driven by healthcare modernization and growing awareness of advanced neurovascular treatments; heavy reliance on imports.

Key Market Players

  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics
  • Codman & Shurtleff
  • Stryker
  • Integra LifeSciences
  • InoMed
  • Mizuho America
  • RauMedic

Here’s a comprehensive intelligence brief for the Global Liquid Embolics Market (2025–2035) with all the requested frameworks:

Global Liquid Embolics Market Intelligence Brief (2025–2035)

Short Description

The global liquid embolics market—covering agents such as isobutyl-2-cyanoacrylate (IBCA), ethanol, sodium morrhuate, and natural extracts like Bletilla striata—is projected to grow steadily through 2035. Liquid embolics are critical in minimally invasive neurovascular procedures, including treatment of brain arteriovenous malformations (AVMs), aneurysms, ischemic strokes, and tumor embolization. Growth is driven by rising incidence of neurological disorders, technological advancements in embolization therapies, and increasing adoption of minimally invasive procedures. Challenges include regulatory hurdles, high treatment costs, and limited access in developing regions.

Regional Analysis

North America (U.S., Canada, Mexico)

  • Largest market due to advanced healthcare infrastructure and high adoption of minimally invasive neurosurgical procedures.
  • Strong presence of leading medical device companies.
  • Growth supported by FDA approvals and reimbursement frameworks.

Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)

  • Mature market with strict EU medical device regulations.
  • High adoption in neurosurgery and oncology.
  • Focus on innovation in embolization agents and patient safety.

Asia-Pacific (China, India, Japan, Southeast Asia, etc.)

  • Fastest-growing region, driven by rising healthcare investments and increasing incidence of neurological disorders.
  • China and India lead in procedure volumes; Japan emphasizes advanced neurovascular technologies.
  • Expanding medical tourism and hospital infrastructure.

South America (Brazil, Argentina, etc.)

  • Moderate growth supported by expanding healthcare systems.
  • Reliance on imports for premium embolic agents.
  • Opportunities in improving access to advanced neurovascular care.

Middle East & Africa (Saudi Arabia, South Africa, etc.)

  • Emerging demand driven by healthcare modernization and growing awareness of advanced neurovascular treatments.
  • Heavy reliance on imports; limited local production capacity.
  • Growth tied to government-backed healthcare initiatives.

Detailed Segmentation Analysis

By Type

  • Isobutyl-2-Cyanoacrylate (IBCA): Synthetic adhesive used in embolization of AVMs and tumors.
  • Ethanol: Widely used for sclerotherapy and embolization of vascular malformations.
  • Sodium Morrhuate: Applied in vascular occlusion therapies.
  • Bletilla Striata: Natural extract with emerging applications in embolization.
  • Others: Novel and experimental embolic agents.

By Application

  • Tumor and Brain Cancer: Embolization for pre-surgical tumor management.
  • Brain Arteriovenous Malformations (AVMs): Major application area for liquid embolics.
  • Ischemic Stroke: Used in occlusion therapies and adjunctive treatments.
  • Brain Aneurysm: Applied in minimally invasive neurovascular procedures.
  • Others: Specialty uses in rare vascular conditions.

Porter’s Five Forces

  1. Threat of New Entrants: Low – high regulatory barriers and R&D costs.
  2. Bargaining Power of Suppliers: Moderate – dependence on specialized raw materials and technology.
  3. Bargaining Power of Buyers: High – hospitals and healthcare providers demand cost-effective, safe, and proven products.
  4. Threat of Substitutes: Moderate – competition from coils, stents, and other embolization devices.
  5. Industry Rivalry: High – intense competition among global medical device companies.

SWOT Analysis

Strengths

  • Essential in minimally invasive neurovascular procedures.
  • Strong demand in oncology and neurosurgery.
  • Expanding applications in stroke and aneurysm treatment.

Weaknesses

  • High treatment costs.
  • Limited access in developing regions.
  • Regulatory hurdles in medical device approvals.

Opportunities

  • Rising incidence of neurological disorders.
  • Growth in Asia-Pacific healthcare infrastructure.
  • Expansion into natural and bio-based embolic agents.

Threats

  • Stringent regulatory compliance requirements.
  • Competition from alternative embolization devices.
  • Supply chain disruptions and geopolitical risks.

Trend Analysis

  • Minimally Invasive Therapies: Rising adoption of liquid embolics in neurovascular procedures.
  • Technological Innovation: Development of advanced embolic agents with improved safety profiles.
  • Asia-Pacific Growth: Rapid expansion in healthcare infrastructure and procedure volumes.
  • Natural Extracts: Emerging interest in bio-based embolic agents.
  • Integration with Imaging: Enhanced precision through advanced imaging-guided embolization.

Drivers & Challenges

Drivers

  • Rising incidence of brain AVMs, aneurysms, and strokes.
  • Technological advancements in embolization therapies.
  • Increasing adoption of minimally invasive procedures.
  • Government-backed healthcare modernization initiatives.

Challenges

  • High treatment costs and limited reimbursement in some regions.
  • Regulatory hurdles in medical device approvals.
  • Intense competition among global and regional players.
  • Limited adoption in cost-sensitive markets.

Value Chain Analysis

  1. Raw Materials: Specialized chemicals and bio-based extracts.
  2. Manufacturing: Formulation of embolic agents, sterilization, and packaging.
  3. Distribution: Global networks supplying hospitals, neurosurgical centers, and oncology clinics.
  4. End-Use Applications: Tumor embolization, AVMs, stroke, aneurysm treatment.
  5. Regulatory Oversight: Compliance with FDA, EU MDR, and international medical device standards.

 

1. Market Overview of Liquid Embolics
    1.1 Liquid Embolics Market Overview
        1.1.1 Liquid Embolics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Liquid Embolics Market Size by Regions:
    1.3 Liquid Embolics Historic Market Size by Regions
    1.4 Liquid Embolics Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Liquid Embolics Sales Market by Type
    2.1 Global Liquid Embolics Historic Market Size by Type
    2.2 Global Liquid Embolics Forecasted Market Size by Type
    2.3 Isobutyl-2-Cyanoacrylate(IBCA)
    2.4 Ethanol
    2.5 Sodium Morrhuate
    2.6 Bletilla Striata
    2.7 Others
3. Covid-19 Impact Liquid Embolics Sales Market by Application
    3.1 Global Liquid Embolics Historic Market Size by Application
    3.2 Global Liquid Embolics Forecasted Market Size by Application
    3.3 Tumor and Brain Cancer
    3.4 Brain Arteriovenous Malformations
    3.5 Ischemic Stroke
    3.6 Brain Aneurysm
    3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Liquid Embolics Production Capacity Market Share by Manufacturers
    4.2 Global Liquid Embolics Revenue Market Share by Manufacturers
    4.3 Global Liquid Embolics Average Price by Manufacturers
5. Company Profiles and Key Figures in Liquid Embolics Business
    5.1 Medtronic
        5.1.1 Medtronic Company Profile
        5.1.2 Medtronic Liquid Embolics Product Specification
        5.1.3 Medtronic Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.2 Boston Scientific
        5.2.1 Boston Scientific Company Profile
        5.2.2 Boston Scientific Liquid Embolics Product Specification
        5.2.3 Boston Scientific Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.3 St. Jude Medical
        5.3.1 St. Jude Medical Company Profile
        5.3.2 St. Jude Medical Liquid Embolics Product Specification
        5.3.3 St. Jude Medical Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.4 Cyberonics
        5.4.1 Cyberonics Company Profile
        5.4.2 Cyberonics Liquid Embolics Product Specification
        5.4.3 Cyberonics Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.5 Codman & Shurtleff
        5.5.1 Codman & Shurtleff Company Profile
        5.5.2 Codman & Shurtleff Liquid Embolics Product Specification
        5.5.3 Codman & Shurtleff Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.6 Stryker
        5.6.1 Stryker Company Profile
        5.6.2 Stryker Liquid Embolics Product Specification
        5.6.3 Stryker Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.7 Integra LifeSciences
        5.7.1 Integra LifeSciences Company Profile
        5.7.2 Integra LifeSciences Liquid Embolics Product Specification
        5.7.3 Integra LifeSciences Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.8 InoMed
        5.8.1 InoMed Company Profile
        5.8.2 InoMed Liquid Embolics Product Specification
        5.8.3 InoMed Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.9 Mizuho America
        5.9.1 Mizuho America Company Profile
        5.9.2 Mizuho America Liquid Embolics Product Specification
        5.9.3 Mizuho America Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
    5.10 RauMedic
        5.10.1 RauMedic Company Profile
        5.10.2 RauMedic Liquid Embolics Product Specification
        5.10.3 RauMedic Liquid Embolics Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Liquid Embolics Market Size
    6.2 North America Liquid Embolics Key Players in North America
    6.3 North America Liquid Embolics Market Size by Type
    6.4 North America Liquid Embolics Market Size by Application
7. East Asia
    7.1 East Asia Liquid Embolics Market Size
    7.2 East Asia Liquid Embolics Key Players in North America
    7.3 East Asia Liquid Embolics Market Size by Type
    7.4 East Asia Liquid Embolics Market Size by Application
8. Europe
    8.1 Europe Liquid Embolics Market Size
    8.2 Europe Liquid Embolics Key Players in North America
    8.3 Europe Liquid Embolics Market Size by Type
    8.4 Europe Liquid Embolics Market Size by Application
9. South Asia
    9.1 South Asia Liquid Embolics Market Size
    9.2 South Asia Liquid Embolics Key Players in North America
    9.3 South Asia Liquid Embolics Market Size by Type
    9.4 South Asia Liquid Embolics Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Liquid Embolics Market Size
    10.2 Southeast Asia Liquid Embolics Key Players in North America
    10.3 Southeast Asia Liquid Embolics Market Size by Type
    10.4 Southeast Asia Liquid Embolics Market Size by Application
11. Middle East
    11.1 Middle East Liquid Embolics Market Size
    11.2 Middle East Liquid Embolics Key Players in North America
    11.3 Middle East Liquid Embolics Market Size by Type
    11.4 Middle East Liquid Embolics Market Size by Application
12. Africa
    12.1 Africa Liquid Embolics Market Size
    12.2 Africa Liquid Embolics Key Players in North America
    12.3 Africa Liquid Embolics Market Size by Type
    12.4 Africa Liquid Embolics Market Size by Application
13. Oceania
    13.1 Oceania Liquid Embolics Market Size
    13.2 Oceania Liquid Embolics Key Players in North America
    13.3 Oceania Liquid Embolics Market Size by Type
    13.4 Oceania Liquid Embolics Market Size by Application
14. South America
    14.1 South America Liquid Embolics Market Size
    14.2 South America Liquid Embolics Key Players in North America
    14.3 South America Liquid Embolics Market Size by Type
    14.4 South America Liquid Embolics Market Size by Application
15. Rest of the World
    15.1 Rest of the World Liquid Embolics Market Size
    15.2 Rest of the World Liquid Embolics Key Players in North America
    15.3 Rest of the World Liquid Embolics Market Size by Type
    15.4 Rest of the World Liquid Embolics Market Size by Application
16 Liquid Embolics Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Global Liquid Embolics Market Segmentation

By Type

  • Isobutyl-2-Cyanoacrylate (IBCA)
  • Ethanol
  • Sodium Morrhuate
  • Bletilla Striata
  • Others

By Application

  • Tumor and Brain Cancer
  • Brain Arteriovenous Malformations (AVMs)
  • Ischemic Stroke
  • Brain Aneurysm
  • Others

Regional Analysis

  • North America (U.S., Canada, Mexico): Strong demand for advanced embolization therapies; emphasis on FDA-approved products and high healthcare expenditure.
  • Europe (Germany, U.K., France, Italy, Russia, Spain, etc.): Mature market with strict EU medical device regulations; high adoption in neurosurgery and oncology.
  • Asia-Pacific (China, India, Japan, Southeast Asia, etc.): Fastest-growing region, driven by rising healthcare infrastructure, increasing incidence of neurological disorders, and adoption of minimally invasive procedures.
  • South America (Brazil, Argentina, etc.): Moderate growth supported by expanding healthcare systems; reliance on imports for premium embolic agents.
  • Middle East & Africa (Saudi Arabia, South Africa, etc.): Emerging demand driven by healthcare modernization and growing awareness of advanced neurovascular treatments; heavy reliance on imports.

Key Market Players

  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics
  • Codman & Shurtleff
  • Stryker
  • Integra LifeSciences
  • InoMed
  • Mizuho America
  • RauMedic

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.